Price Move History
- Daily moves over 5%
- 27 69 sessions, November 5, 2025 to November 5, 2026
- Largest daily move
- +100.5% close of October 21, 2026
Company Description
Agentix (OTC: AGTX) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $1.4M.
AGTX has declined 7.5% over the past week. The last closing price was $0.0490.
For FY2026, Agentix reported diluted earnings per share of -$0.01.
This page collects what Stock Titan holds for AGTX, including price data, SEC filings, financial highlights, and short interest trends.
Stock Performance
Agentix (AGTX) closed at $0.0490 on November 5, 2026. Over the past week, the price has lost 7.5%.
AGTX Metrics & Rankings
Price returns through November 5, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
SEC Filings
Agentix has filed 5 recent SEC filings, including 4 Form 10-Q, 1 Form 10-K. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all AGTX SEC filings →
Financial Highlights
Agentix reported diluted earnings per share of -$0.01 in FY2026. The current ratio was 0.00, measuring current assets divided by current liabilities.
Upcoming Events
Short Interest History
Short interest in Agentix (AGTX) currently stands at 18 shares, representing 0.0% of the float. Since December 2025, short interest has increased by 38.5%.
Days to Cover History
Days to cover for Agentix (AGTX) currently stands at 1000.0 days. The ratio is the reported short interest divided by the average daily trading volume. Since December 2025, the figure has increased by 99899%. Across the settlements charted above, it has ranged from 1.0 to 1000.0 days.
AGTX Company Profile & Sector Positioning
Agentix (AGTX) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing AGTX often look at related companies in the same sector, including Enzolytics Inc (ENZC), Vaxxinity Inc A (VAXX), Vaccinex Inc (VCNX), Avenue Therapeutics Inc (ATXI), and America Great Health (AAGH). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate AGTX's relative position within its industry.